BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14764533)

  • 1. Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3.
    Peltola KJ; Paukku K; Aho TL; Ruuska M; Silvennoinen O; Koskinen PJ
    Blood; 2004 May; 103(10):3744-50. PubMed ID: 14764533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin.
    Jegalian AG; Wu H
    J Biol Chem; 2002 Jan; 277(3):2345-52. PubMed ID: 11696536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pim serine/threonine kinases regulate the stability of Socs-1 protein.
    Chen XP; Losman JA; Cowan S; Donahue E; Fay S; Vuong BQ; Nawijn MC; Capece D; Cohan VL; Rothman P
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2175-80. PubMed ID: 11854514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
    Flores-Morales A; Fernández L; Rico-Bautista E; Umana A; Negrín C; Zhang JG; Norstedt G
    Mol Endocrinol; 2001 Sep; 15(9):1471-83. PubMed ID: 11518796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation.
    Nosaka T; Kitamura T
    Exp Hematol; 2002 Jul; 30(7):697-702. PubMed ID: 12135666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5.
    Paukku K; Silvennoinen O
    Cytokine Growth Factor Rev; 2004 Dec; 15(6):435-55. PubMed ID: 15561601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact.
    van de Geijn GJ; Gits J; Aarts LH; Heijmans-Antonissen C; Touw IP
    Blood; 2004 Aug; 104(3):667-74. PubMed ID: 15069015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
    Cacalano NA; Sanden D; Johnston JA
    Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
    Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T
    EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of SOCS family members in EpoR signal transduction.
    Jegalian AG; Wu H
    J Interferon Cytokine Res; 2002 Aug; 22(8):853-60. PubMed ID: 12396724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
    Hoover RR; Gerlach MJ; Koh EY; Daley GQ
    Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
    Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
    Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S; Chughtai N; Ali S
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis.
    Nieborowska-Skorska M; Hoser G; Kossev P; Wasik MA; Skorski T
    Blood; 2002 Jun; 99(12):4531-9. PubMed ID: 12036885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
    Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
    Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
    Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
    J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
    Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
    Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
    Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.